Qi-Ying is drug discovery leader with 20+ years’ experience in large pharma and biotech. Extensive experience in leading discovery and platform team, and advancing candidates into clinical studies.
- Co-inventor of one FDA approved drug: Isturisa® [LCI699, FDA & EMA approval in 2020]
- Over 40 patents, 30 publications and 1 book chapter
- Expert in non-viral delivery of RNA
- Diverse target scope and broad disease areas
